Close Menu

NEW YORK (GenomeWeb) – Phenomix Sciences — an early-stage spinout of the Mayo Clinic focused on personalized treatments for chronic diseases — announced today that it is launching a $1 million seed financing round through a crowdfunding platform.

The privately held firm said it intends to use the financing to commercialize a new clinical test for obesity. The diagnostic uses technology developed by the Mayo Clinic to analyze metabolomic and DNA biomarkers to characterize obesity and guide more effective weight loss treatments.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.